Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.
Ala-Hurula V, Myllylä VV, Arvela P, Heikkilä J, Kärki N, Hokkanen E.
Ala-Hurula V, et al.
Eur J Clin Pharmacol. 1979 Feb 19;15(1):51-5. doi: 10.1007/BF00563557.
Eur J Clin Pharmacol. 1979.
PMID: 421728
Ergotamine tartrate was given in doses normally used in the treatment of acute migraine--2.0 mg orally, 2.0 mg combined with 100 mg caffeine rectally and 0.5 mg i.m. Plasma ergotamine concentrations were determined by radioimmunoassay. ...The corresponding maximum concentr …
Ergotamine tartrate was given in doses normally used in the treatment of acute migraine--2.0 mg orally, 2.0 mg combined with 100 mg caffe …